At first glance, the newest device from PNOĒ presents a striking silhouette, reminiscent of a prop from a high-stakes cinematic thriller. The mask, engineered to precisely cover the nose and mouth while strapping securely around the back of the head, bears an undeniable aesthetic parallel to the formidable facial apparatus worn by Bane, Batman’s hulking nemesis. However, any initial apprehension evoked by its design quickly dissipates upon understanding its true purpose: a sophisticated instrument designed for profound personal insight, measuring oxygen consumption and carbon dioxide exhalation to transform raw physiological data into actionable guidance on nutrition, exercise, and ultimately, an enhanced quality of life. This benign mission stands in stark contrast to its villainous aesthetic inspiration, aiming instead to empower individuals on their journey toward improved health and longevity.
A New Era of Accessibility: The PNOĒ 2.0 Revolution
PNOĒ, a company with dual operational bases in Malden, Massachusetts, and Athens, Greece, is on the cusp of a significant market launch with its PNOĒ 2.0 device, slated for October 1. This iteration marks a pivotal evolution from its predecessor, primarily through the introduction of user self-administration capabilities. Apostolos Atsalakis, co-founder and CEO, recently articulated the device’s streamlined user experience during a Zoom call from the company’s Athens hub: "Someone can walk into a gym, just wear the mask, push the button, sit down, and breathe for eight minutes. That’s it. It’s that easy." This ease of use is not merely a convenience; it represents a fundamental shift in how advanced metabolic testing can be integrated into everyday wellness routines.
The ability for users to conduct tests independently is a profound differentiator. PNOĒ’s initial device necessitated a trained operator, a requirement that inherently restricted its deployment to specialized facilities with dedicated personnel. The PNOĒ 2.0, by eliminating this barrier, unlocks vast new market potential. Atsalakis envisions the self-serve model extending to a broader spectrum of venues, including fitness centers without specialized staff and potentially even pharmacies, transforming them into accessible hubs for metabolic health assessments. This expansion signifies a strategic move to democratize a technology traditionally confined to elite circles.
The Enduring Science of Metabolic Analysis
The scientific underpinnings of PNOĒ’s technology are robust and well-established, drawing from over a century of metabolic testing research. This field, which involves analyzing the gases exchanged during respiration to quantify how the body generates energy, has long been revered as the "gold standard" for measuring key physiological markers. Chief among these is VO₂ max, which denotes the maximum rate at which the body can consume oxygen during strenuous exercise. VO₂ max is a universally recognized and highly valued metric for assessing cardiorespiratory fitness, with strong correlations to overall health and endurance capabilities.
Historically, the prohibitive cost, bulk, and complexity of traditional metabolic carts meant that these sophisticated analyses were predominantly the domain of elite athletes, advanced sports science laboratories, and exclusive executive wellness programs. These systems, often costing tens of thousands of dollars and requiring significant space and specialized training to operate, created an insurmountable barrier for the general public. PNOĒ, a company now celebrating its tenth year, entered this landscape with a bold promise: to deliver comparable accuracy within a portable, user-friendly package, seamlessly integrated with software that translates intricate physiological data into intuitive, actionable recommendations. "We made it accessible to everyone," Atsalakis affirms, encapsulating the company’s core mission.
Unlocking Comprehensive Biomarkers for Personalized Health
PNOĒ’s system is engineered to capture a comprehensive array of 23 biomarkers. Beyond the crucial VO₂ max, the device measures resting metabolic rate (RMR), which indicates the number of calories the body expends at rest—a foundational metric for weight management and nutritional planning. Another vital biomarker is metabolic flexibility, assessing the body’s efficiency in switching between burning fats and carbohydrates for energy. This adaptability is increasingly recognized as a cornerstone of metabolic health, impacting everything from athletic performance to chronic disease prevention. Atsalakis contends that these breath-derived metrics provide insights that traditional blood tests cannot, such as precise caloric needs or optimal training methodologies tailored to an individual’s unique metabolism.
The timing for PNOĒ’s advancements aligns perfectly with a burgeoning global interest in longevity and preventive health. VO₂ max, once a niche metric, has evolved into a significant buzzword among longevity enthusiasts, fueled by a growing body of research unequivocally linking higher cardiorespiratory fitness to reduced mortality and an extended healthspan. Atsalakis describes VO₂ max as "the strongest predictor of human longevity," positioning PNOĒ’s data as an indispensable "scorecard" for participants and practitioners within the rapidly expanding wellness industry. This confluence of scientific validation and public awareness creates a fertile ground for PNOĒ’s innovative solutions.
Engineering for Precision and User-Centric Design
The PNOĒ 2.0 represents a considerable leap in industrial design and engineering. It is notably smaller and more compact than its predecessor, featuring fewer components, which Atsalakis notes enhances its reliability and durability. The device’s development involved a collaborative effort with Milan-based Design Group Italia, a process Atsalakis characterized as involving "a lot, a lot, a lot of iterations." This intensive design cycle was necessitated by the unprecedented challenge of creating a self-administered metabolic testing device—a product category that simply did not exist before PNOĒ. The iterative design philosophy ensured not only functional excellence but also an intuitive user experience that belies the complex science beneath.
A critical design consideration, particularly in the post-pandemic era, was addressing hygiene concerns related to shared equipment. The PNOĒ 2.0 ingeniously resolves the "who wore it last?" dilemma by allowing the electronic core to detach completely from the silicone mask and straps. This modular design means that multiple users can share the more costly electronic hardware, while each individual maintains their own personal, hygienic mask and strap set. This thoughtful solution enhances user confidence, simplifies cleaning protocols for facilities, and optimizes the economic model for businesses investing in the technology.
Navigating the Regulatory Landscape: Wellness vs. Medical Device
Despite its profound clinical potential, PNOĒ maintains a judicious approach to its claims and regulatory positioning. The device is not cleared by the U.S. Food and FDA (Food and Drug Administration), and Atsalakis explicitly states, "we do not provide medical recommendations." PNOĒ firmly categorizes itself as a wellness device, drawing parallels to widely accepted tools like body composition scales. "A doctor cannot prescribe medication based on our results," Atsalakis clarifies, underscoring the distinction between wellness insights and clinical diagnostics. This careful self-classification is crucial for operating within the current regulatory framework, allowing PNOĒ to offer powerful health insights without crossing into medical diagnostic territory, which entails much more stringent and time-consuming approval processes.
Future Horizons: Breathomics and Disease Detection
While currently positioned within the wellness sector, PNOĒ harbors ambitious long-term aspirations that extend into the realm of medical diagnostics. Researchers globally have long investigated the potential of "breathomics"—the analysis of volatile organic compounds (VOCs) and other markers in human breath—to signal the presence of diseases such as cancer, diabetes, and infectious agents. Atsalakis believes that PNOĒ’s accumulating trove of metabolic data, combined with advanced analytical capabilities, could eventually enable the company to flag potential health issues. However, he candidly acknowledges that achieving full diagnostic capabilities is "definitely a couple of years away," with significant scientific validation and regulatory hurdles likely extending this timeline further. "We’re not there yet," he reiterates, emphasizing a cautious and evidence-based approach to future development.
From Academic Research to a Global Health Enterprise
PNOĒ’s origins are rooted in Apostolos Atsalakis’s PhD research in sensing technologies at the University of Cambridge. During a period when wearable technology was rapidly gaining traction, Atsalakis became captivated by the rich tapestry of information that human breath could reveal about the body’s internal state. This academic curiosity blossomed into an entrepreneurial venture when he co-founded PNOĒ with Panos Papadiamantis, a childhood friend who now serves as the company’s chief product officer. Their shared vision and complementary expertise laid the groundwork for the company’s innovative trajectory.
The startup gained early momentum as part of Y Combinator’s Winter 2019 batch, a time when the concept of "longevity" was still nascent and not yet the burgeoning industry it is today. This early incubation provided crucial support and mentorship, propelling PNOĒ forward. Since then, the company has successfully raised approximately $22 million in funding, including a recently concluded $11 million round. Its investor base includes prominent firms like 50 Years and notable individuals such as Lars Rasmussen, co-founder of Google Maps, who is now based in Athens and actively involved in the European tech ecosystem. This robust financial backing underscores investor confidence in PNOĒ’s technology, market strategy, and long-term potential.
A Business-to-Business Model Driving Broad Adoption
PNOĒ employs a strategic business-to-business (B2B) model, selling its devices and services exclusively to enterprises that then offer the metabolic testing to their own clientele. This approach has enabled rapid penetration into diverse high-end markets. Its impressive roster of clients includes global luxury fitness chain Equinox, where the PNOĒ test is available at almost all clubs, according to Atsalakis. Other esteemed partners include Four Seasons hotels, energy drink giant Red Bull, the National Basketball Association (NBA), the prestigious Mount Sinai Health System, and the rapidly expanding med spa chain Restore Hyper Wellness. These partnerships illustrate the broad appeal and versatility of PNOĒ’s technology across fitness, hospitality, professional sports, healthcare, and aesthetic wellness sectors.
The United States currently accounts for approximately 85% of PNOĒ’s business, a market Atsalakis identifies as "by far the most advanced globally" for longevity-focused innovations. Building on this strong foundation, the company is now actively expanding its footprint in Europe and, through strategic partnerships, into Latin America and Asia, aiming to establish a truly global presence for accessible metabolic health insights.
Businesses subscribe to PNOĒ’s service with monthly fees ranging from $400 to over $1,000. This comprehensive subscription package includes the hardware, proprietary software, necessary training, and marketing materials—a holistic offering Atsalakis aptly terms a "business in a box." A key feature of PNOĒ’s platform is its ability to link test results directly to the services a business provides. For instance, a gym or spa can leverage a customer’s metabolic profile to recommend highly personalized fitness regimens, nutritional plans, or wellness treatments. Many clients integrate the PNOĒ test into their onboarding processes, positioning it as an invaluable tool that bridges the gap between a full clinical workup and the often-estimated metrics provided by consumer smartwatches.
Navigating a Crowded Wellness Technology Landscape
The "middle ground" of personalized health metrics, situated between clinical diagnostics and general consumer wearables, is an increasingly competitive arena. Leading tech giants like Apple, Garmin, and Whoop all offer estimated VO₂ max measurements derived from heart-rate data collected by their respective devices. On the consumer breath analysis front, devices such as Lumen provide insights into fat and carbohydrate burning ratios. At the higher end of the spectrum, traditional metabolic carts continue to be the undisputed standard in specialized laboratories and hospitals, albeit with their inherent limitations in terms of accessibility and cost.
PNOĒ distinguishes itself by offering the precision and comprehensive biomarker analysis traditionally associated with laboratory-grade equipment, packaged into an accessible, self-administered device. Its ability to provide accurate RMR, metabolic flexibility, and a detailed VO₂ max, coupled with actionable software recommendations, carves out a unique and compelling niche in this evolving market.
Financial Health and Future Growth Trajectory
PNOĒ, which currently employs a team of 110 professionals, recently achieved profitability, a significant milestone for a rapidly growing tech startup. The company has demonstrated impressive growth, expanding by over 100% annually, indicative of strong market demand and effective execution. Looking ahead, Atsalakis revealed plans to pursue a Series B funding round within the next six to twelve months. This capital injection will be instrumental in fueling PNOĒ’s continued expansion, enabling it to put its distinctive mask—Bane comparisons and all—in front of an ever-wider audience, further solidifying its position as a leader in democratizing metabolic health insights for global wellness and longevity. The company’s trajectory suggests a future where precise, personalized metabolic data is not a luxury, but an accessible tool for everyone seeking to optimize their health and extend their vibrant years.
